FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966175035> ?p ?o ?g. }

• W1966175035 endingPage "961" @default.
• W1966175035 startingPage "961" @default.
• W1966175035 abstract "<h3>Objectives.</h3> —To determine whether the administration of 1.5 million units of streptokinase intravenously within 4 hours of the onset of acute ischemic stroke would reduce morbidity and mortality at 3 months and whether outcomes may be better for those receiving therapy within 3 hours of stroke onset compared with those receiving it after 3 hours. <h3>Design.</h3> —Randomized, double-blind, placebo-controlled trial with 3-month follow-up. <h3>Participants.</h3> —A total of 340 patients, aged 18 to 85 years, with moderate to severe strokes were randomized from 40 centers throughout Australia from June 1992 to November 1994. <h3>Intervention.</h3> —Administration of 1.5 million units of streptokinase or placebo intravenously in 100 mL of normal saline over 1 hour. <h3>Main Outcome Measure.</h3> —Combined death and disability score (Barthel index <60) 3 months after the stroke. <h3>Results.</h3> —Using an intention-to-treat analysis with a combined death and disability score at 3 months after stroke as the primary end point, we found a nonsignificant overall trend toward unfavorable outcomes for streptokinase vs placebo (relative risk [RR] of unfavorable outcome, 1.08; 95% confidence interval [CI], 0.74-1.58) and an excess of hematomas (13.2% [12.6% symptomatic] in the treated group, 3% [2.4% symptomatic] for placebo [<i>P</i><.01] ). However, poor outcomes were confined to patients receiving therapy more than 3 hours after stroke onset (RR of unfavorable outcome, 1.22; 95% CI, 0.80-1.86). In contrast, among the 70 patients who were entered into the trial within 3 hours of stroke onset, there was a trend toward improved outcomes for those who received streptokinase (RR of unfavorable outcome, 0.66; 95% CI, 0.28-1.58), and this outcome pattern was significantly better than for those receiving therapy after 3 hours (<i>P</i>=.04). Streptokinase administration resulted in excess deaths in the group treated after 3 hours (RR, 1.98; 95% CI, 1.18-3.35), but not among those treated within 3 hours (RR, 1.11; 95% CI, 0.38-3.21). <h3>Conclusion.</h3> —The administration of streptokinase within 4 hours of acute ischemic stroke increased morbidity and mortality at 3 months. While treatment within 3 hours of stroke was safer and associated with significantly better outcomes than later treatment, it showed no significant benefit over placebo. The timing of thrombolytic therapy for acute stroke is critical." @default.
• W1966175035 created "2016-06-24" @default.
• W1966175035 creator A5017270773 @default.
• W1966175035 creator A5017489904 @default.
• W1966175035 creator A5023948758 @default.
• W1966175035 creator A5039358787 @default.
• W1966175035 creator A5057379795 @default.
• W1966175035 creator A5059045910 @default.
• W1966175035 creator A5076785778 @default.
• W1966175035 creator A5087408320 @default.
• W1966175035 creator A5091275703 @default.
• W1966175035 date "1996-09-25" @default.
• W1966175035 modified "2023-09-30" @default.
• W1966175035 title "Streptokinase for Acute Ischemic Stroke With Relationship to Time of Administration" @default.
• W1966175035 cites W1972187733 @default.
• W1966175035 cites W1973982955 @default.
• W1966175035 cites W1976299524 @default.
• W1966175035 cites W1986239469 @default.
• W1966175035 cites W2016807740 @default.
• W1966175035 cites W2016998465 @default.
• W1966175035 cites W2018281076 @default.
• W1966175035 cites W2020437523 @default.
• W1966175035 cites W2039392119 @default.
• W1966175035 cites W2059217502 @default.
• W1966175035 cites W2068371880 @default.
• W1966175035 cites W2079846047 @default.
• W1966175035 cites W2081769749 @default.
• W1966175035 cites W2083268271 @default.
• W1966175035 cites W2083737728 @default.
• W1966175035 cites W2084264023 @default.
• W1966175035 cites W2087046456 @default.
• W1966175035 cites W2110814699 @default.
• W1966175035 cites W2119571563 @default.
• W1966175035 cites W2123351961 @default.
• W1966175035 cites W2130217220 @default.
• W1966175035 cites W2131659895 @default.
• W1966175035 cites W2143631659 @default.
• W1966175035 cites W2157281786 @default.
• W1966175035 cites W2164492024 @default.
• W1966175035 cites W2244796790 @default.
• W1966175035 cites W2292308933 @default.
• W1966175035 cites W23720808 @default.
• W1966175035 cites W2411713730 @default.
• W1966175035 cites W2463922980 @default.
• W1966175035 cites W2478734695 @default.
• W1966175035 cites W2133310936 @default.
• W1966175035 doi "https://doi.org/10.1001/jama.1996.03540120039031" @default.
• W1966175035 hasPublicationYear "1996" @default.
• W1966175035 type Work @default.
• W1966175035 sameAs 1966175035 @default.
• W1966175035 citedByCount "279" @default.
• W1966175035 countsByYear W19661750352012 @default.
• W1966175035 countsByYear W19661750352013 @default.
• W1966175035 countsByYear W19661750352014 @default.
• W1966175035 countsByYear W19661750352015 @default.
• W1966175035 countsByYear W19661750352016 @default.
• W1966175035 countsByYear W19661750352017 @default.
• W1966175035 countsByYear W19661750352018 @default.
• W1966175035 countsByYear W19661750352019 @default.
• W1966175035 countsByYear W19661750352020 @default.
• W1966175035 countsByYear W19661750352021 @default.
• W1966175035 countsByYear W19661750352022 @default.
• W1966175035 countsByYear W19661750352023 @default.
• W1966175035 crossrefType "journal-article" @default.
• W1966175035 hasAuthorship W1966175035A5017270773 @default.
• W1966175035 hasAuthorship W1966175035A5017489904 @default.
• W1966175035 hasAuthorship W1966175035A5023948758 @default.
• W1966175035 hasAuthorship W1966175035A5039358787 @default.
• W1966175035 hasAuthorship W1966175035A5057379795 @default.
• W1966175035 hasAuthorship W1966175035A5059045910 @default.
• W1966175035 hasAuthorship W1966175035A5076785778 @default.
• W1966175035 hasAuthorship W1966175035A5087408320 @default.
• W1966175035 hasAuthorship W1966175035A5091275703 @default.
• W1966175035 hasConcept C126322002 @default.
• W1966175035 hasConcept C127413603 @default.
• W1966175035 hasConcept C142724271 @default.
• W1966175035 hasConcept C164705383 @default.
• W1966175035 hasConcept C168563851 @default.
• W1966175035 hasConcept C187212893 @default.
• W1966175035 hasConcept C204787440 @default.
• W1966175035 hasConcept C27081682 @default.
• W1966175035 hasConcept C2776336681 @default.
• W1966175035 hasConcept C2780645631 @default.
• W1966175035 hasConcept C42219234 @default.
• W1966175035 hasConcept C44249647 @default.
• W1966175035 hasConcept C500558357 @default.
• W1966175035 hasConcept C71924100 @default.
• W1966175035 hasConcept C78519656 @default.
• W1966175035 hasConcept C82789193 @default.
• W1966175035 hasConceptScore W1966175035C126322002 @default.
• W1966175035 hasConceptScore W1966175035C127413603 @default.
• W1966175035 hasConceptScore W1966175035C142724271 @default.
• W1966175035 hasConceptScore W1966175035C164705383 @default.
• W1966175035 hasConceptScore W1966175035C168563851 @default.
• W1966175035 hasConceptScore W1966175035C187212893 @default.
• W1966175035 hasConceptScore W1966175035C204787440 @default.
• W1966175035 hasConceptScore W1966175035C27081682 @default.
• W1966175035 hasConceptScore W1966175035C2776336681 @default.

• next